A detailed history of Harbor Capital Advisors, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 46,757 shares of MRK stock, worth $4.04 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
46,757
Previous 46,014 1.61%
Holding current value
$4.04 Million
Previous $3.64 Million 7.74%
% of portfolio
0.3%
Previous 0.15%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 15, 2025

BUY
$77.6 - $87.37 $57,656 - $64,915
743 Added 1.61%
46,757 $3.92 Million
Q2 2025

Jul 09, 2025

SELL
$73.47 - $87.12 $12,710 - $15,071
-173 Reduced 0.37%
46,014 $3.64 Million
Q1 2025

Apr 14, 2025

BUY
$83.01 - $101.02 $3.68 Million - $4.47 Million
44,276 Added 2316.9%
46,187 $4.15 Million
Q4 2024

Jan 10, 2025

BUY
$96.31 - $114.76 $40,257 - $47,969
418 Added 28.0%
1,911 $190,000
Q3 2024

Oct 29, 2024

BUY
$111.15 - $128.97 $20,007 - $23,214
180 Added 13.71%
1,493 $170,000
Q2 2024

Jul 09, 2024

SELL
$123.8 - $132.96 $1,980 - $2,127
-16 Reduced 1.2%
1,313 $163,000
Q1 2024

May 13, 2024

SELL
$113.24 - $131.95 $4.71 Million - $5.48 Million
-41,555 Reduced 96.9%
1,329 $175,000
Q4 2023

Jan 08, 2024

BUY
$100.18 - $109.02 $9,316 - $10,138
93 Added 0.22%
42,884 $4.68 Million
Q1 2023

Apr 26, 2023

BUY
$102.94 - $114.86 $4.32 Million - $4.82 Million
41,991 Added 5248.88%
42,791 $4.55 Million
Q4 2022

Jan 20, 2023

SELL
$87.44 - $112.11 $19,149 - $24,552
-219 Reduced 21.49%
800 $0
Q3 2022

Oct 28, 2022

SELL
$84.53 - $94.96 $59,931 - $67,326
-709 Reduced 41.03%
1,019 $88,000
Q2 2022

Jul 26, 2022

SELL
$83.49 - $94.64 $38,572 - $43,723
-462 Reduced 21.1%
1,728 $158,000
Q1 2022

Apr 28, 2022

BUY
$73.51 - $82.4 $160,986 - $180,456
2,190 New
2,190 $180,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $219B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Harbor Capital Advisors, Inc. Portfolio

Follow Harbor Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbor Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbor Capital Advisors, Inc. with notifications on news.